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[Intervention Review] 
INTERVENTIONS FOR PREVENTING HOSPITAL-ACQUIRED 
LEGIONNAIRES’ DISEASE 
 
A B S T R A C T  
Background    
Legionnaires’ Disease (LD) has been recognized as a significant source of morbidity and mortality in many 
hospitals worldwide. Legionella in the hospital water distribution system has been epidemiologically linked to 
hospital-acquired LD. Despite the several disinfection methods available the optimal method to control hospital-
acquired LD has not been established yet.  
Objectives    
To assess the efficacy of interventions for preventing hospital-acquired LD in hospitalized patients at high risk of 
developing the disease and the effect on environmental colonization associated to the risk of developing hospital-
acquired LD.  
Search Methods    
We searched The Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library and 
MEDLINE (PubMed). We also handsearched the reference lists of all primary studies identified by the initial 
search.  
Selection Criteria    
All controlled studies investigating the efficacy of interventions for the prevention of hospital-acquired LD, in 
hospitalized patients at high-risk for developing LD, were eligible for inclusion.  
Data collection and analysis    
Two authors independently assessed the trials and extracted data. Data was analysed using statistical software, 
Review Manager 5.2. 
Results    
Three controlled trials, two assessing copper-silver ionization and one assessing ultraviolet light (UVL), met the 
inclusion criteria. The meta-analysis showed a significant benefit in using copper-silver ionization rather than no 
intervention for Legionella positivity in distal sites, with RR = 0.04 (95% CI Fixed Effects 0.001, 0.29). One study 
demonstrated benefit of UVL versus no intervention with a RR = 0.03 (95% CI 0.00, 0.41) for Legionella positivity 
in water samples.  
Authors’ conclusions  
Our review demonstrates that copper-silver ionization and UVL are beneficial, compared with no treatment, to 
prevent hospital-acquired LD. However the quality of the body of evidence identified does not allow a robust 
conclusion regarding the effectiveness of interventions for preventing hospital-acquired LD.  
Further research with well design and high quality studies is needed.
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B A C K G R O U N D 
 
Description of the condition 
Definition 
Legionnaires' disease (LD) is a severe multisystem 
illness and potentially fatal form of pneumonia, caused 
by bacteria of the genus Legionella (Silva 1996). The 
main clinical manifestations include sudden onset of 
pneumonia with high fever, myalgia, headache, 
dyspnea, nonproductive cough as well as systemic 
manifestations such as diarrhea, nausea, vomiting and 
neurological changes. Important laboratory data 
includes liver function abnormalities, hyponatremia and 
hypophosphatemia (Mandell 2010; Pedro-Botet 2011 
Sabria 2002). Although this symptom complex does 
occur in LD it is not sufficiently distinctive to clinically 
differentiate it from other causes of pneumonia 
(Murdoch; Silva 1996). The key to diagnosis relies on 
the use of specialized laboratory methods, when a 




Legionella spp are small, gram-negative bacilli, obligate 
aerobes, with fastidious growth requirements (Fields 
2002; McDade 1977). Water is the major reservoir for 
Legionella, and the bacteria are ubiquitous in natural and 
artificial water environments worldwide and survive in 
a large variety of habitats and conditions. Legionella 
multiplies at temperatures between 25 and 42ºC, with 
an optimal growth temperature of 35ºC (Fields 2002; 
Newton 2010). 
The environmental factors involved in outbreaks or 
isolated cases of Legionella infection are not completely 
understood, but certain events are considered 
prerequisites for this infection. These factors include 
the presence of virulent strains in an aquatic 
environment, the amplification of the bacteria to obtain 
an infectious dose, a mean for dissemination, such as 
by aerosolization, and transmission of the bacteria 
through contaminated water, to a human host 
susceptible to the disease. 
The main mode of transmission of LD is inhalation of 
microorganisms in aerosols spread mainly from 
showers and taps, cooling towers and condensers of air 
conditioning systems, equipment used in respiratory 
therapy and hot tubs. Another form of transmission is 
microaspiration of contaminated water into the lung. 
There is no evidence of the possibility of direct 
transmission, person-to-person (Mandell 2010; Murray 
1995; Silva 1996).  
Although Legionella strains can cause disease in 
apparently healthy individuals, the likelihood of being 
infected and progressing to serious illness is dependent 
firstly on the type and intensity of exposure and 
secondly on individual susceptibility. Host risk factors 
for LD include male gender, age older than 50 years, 
smoking, underlying chronic disease, 
immunosuppression associated in particular to solid 
organ transplantation and therapy with high doses of 




LD is recognized as an important hospital-acquired 
disease because the natural habitat of these organisms 
is water and they are widespread in institutional water 
systems (Lin 2011a; Sabria 2002). The complex 
networks of pipes of water distribution systems provide 
ideal conditions for Legionella replication. Hospitals 
represent ideal settings for the transmission of the 
disease also because people with predisposing risk 
factors, such as immunocompromised and cancer 
patients, are more likely to be present and in high 
number.  Furthermore, hospitals are places in which 
medical devices, that can disseminate Legionella into the 
lower respiratory tract, are used routinely such as 
respiratory therapy equipment (Sabria 2002). 
In the decade since its initial description, LD 
pneumonia has been recognized as a significant source 
of morbidity and mortality in many hospitals 
worldwide. Reports of epidemics and outbreaks of 
hospital-acquired LD pneumonia occurring in 
association with Legionella colonization of potable water 
systems of hospitals have become commonplace (Lin 
2011a; Sabria 2002). Therefore, hospitals have a special 
responsibility for preventing LD. 
Since it is not possible to eradicate Legionella in a 
hospital environment it is necessary to minimize their 
proliferation and thus decrease the risk of infection. 
The best way to prevent the disease lies in early 
diagnosis of cases and intervention on the potential 




True incidence of hospital-acquired infections is not 
known because LD is under-diagnosed and under-
reported in all countries (Murdoch 2003; Sabria 2002). 
Despite increased awareness and the advances in the 
treatment of these infections, the mortality rate for 
hospital-acquired Legionella pneumonia, according to 
World Health Organization, remains in the range of 40 
and 80% in immunocompromised patients, when left 
untreated. In cases correctly diagnosed in which 
directed therapy is applied in time, the rate may be 
reduced to 5-30%. In individuals with immune 
response capacity, the death rate varies between 10-
15% (WHO 2011). 
 
Description of the intervention 
 
Measures to prevent Legionella in hospitals can be 
considered primary and secondary. First line prevention 
measures, i.e., measures to prevent Legionella with no 
previous documented cases of hospital-acquired LD, 
are appropriate laboratory diagnostic methods and a 
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water system well designed and maintained in 
accordance with national standards. 
Secondary prevention, i.e., preventing further cases 
occurring when a case has been confirmed, should 
include an investigation to exclude the hospital water 
system as a source. 
Legionella in the hospital water distribution system has 
been epidemiologically linked to hospital-acquired LD 
(Lin 2011a; Stout 2007). The assessment of the risk of 
infection must take into account the different reservoirs 
in hospital plumbing systems such as hot and cold 
water, cooling systems (cooling towers, air 
conditioning, humidifying systems) and equipment 
used in respiratory therapy (Silva 1996). 
Disinfection of water systems reduces the numbers of 
Legionella, algae, fungi, protozoa and other bacteria that 
may provide nutrients for the growth of Legionella. 
Several methods of disinfection are available and have 
been used either singly or in combination such as 
temperature control, copper-silver ionization units, 
chlorination (hyperchlorination, chlorine dioxide, 
monochloramine), ultraviolet light (UVL) and point-of-
use filtration. 
 Temperature control was the first method used to 
control Legionella in hospital water systems. Cold water 
systems should be maintained at a temperature <20°C, 
while hot water should be stored above 60°C. 
Superheat-and-flush can be used for emergency control 
of Legionella because it requires no special equipment 
and can be initiated expeditiously Care is needed to 
avoid much higher temperatures because of the risk of 
scalding. (Kim 2002; Lin 1998). 
Copper and silver ions are bactericidal in vitro against 
Legionella. The disinfecting action is attributed to the 
positively charged copper and silver ions which form 
electrostatic bonds with negatively charged sites on the 
bacteria’s cell wall. These electrostatic bonds create 
stresses leading to distorted cell wall permeability. This 
action, coupled with protein denaturation, leads to cell 
lysis and death (Kim 2002; Lin 2011b). 
Chlorination includes strategies such as 
hyperchlorination, chlorine dioxide and 
monochloramine. Hyperchlorination implies that 
additional chlorine is added to water with an existing 
chlorine residual. Chlorine dioxide is a gas in solution 
that kills microorganisms by disruption of the transport 
of nutrients across the cell wall. Monochloramine is a 
chemical produced when ammonia is added to 
chlorinated water. Monochloramine can kill bacteria by 
penetration of the cell wall and blockage of the 
metabolism (Kim 2002; Lin 2011b). 
UV light is an attractive option for disinfection since 
no chemicals are added to the water distribution 
system. Ultraviolet light kills bacteria by disrupting 
cellular DNA synthesis. When UV energy is absorbed 
by the reproductive mechanisms of bacteria, the genetic 
material is rearranged and they can no longer reproduce 
(Kim 2002; Lin 2011b). 
Point-of-use filters are physical barriers, specially used 
for high risk patients, in intensive care units and 
transplant units (Lin 2011b). 
  
Despite the several methods available the optimal 
method to control hospital-acquired LD has not been 
established yet. 
 
Why it is important to do this review 
 
Interventions for prevention hospital-acquired LD 
should be mandatory in every hospital due to morbidity 
and mortality rates associated with this disease. In times 
of financial resources contention in healthcare, the 
correct implementation of effective measures will be 
both life-saving and less expensive in the long run.  
Infection control committee should play the leadership 
role in selecting and evaluating the specific disinfection 
modality. Recommendations for prevention in Hotels 
and other tourist accommodation (2005), were 
elaborated by EWGLI and later approved by the 
European Commission, but nothing has been 
published by this particular group or by the recently 
created ELDSNET of ECDC, regarding Prevention in 
Hospitals.  
Hospitals are increasingly faced with the decision of 
choosing a Legionella disinfection method. Accordingly, 
is important to review evidence regarding the efficacy 
of these interventions. 
 
 
O B J E C T I V E S 
To assess the efficacy of interventions for preventing 
hospital-acquired LD in hospitalized patients at high 
risk of developing the disease and the effect on 
environmental colonization associated to the risk of 
developing hospital-acquired LD.  
 
 
ME T H O D S 
 
Criteria for considering studies for this 
review 
Types of studies 
We considered controlled studies for inclusion, 
investigating the efficacy of interventions preventing 
hospital-acquired LD and the effect on environmental 
colonization by Legionella. 
 
Types of participants  
We considered hospitalized patients at high risk of 
developing hospital-acquired LD (male gender, age 
older than 50 years, smoking, underlying chronic 
disease, immunosuppression associated in particular to 
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solid organ transplantation and therapy with high doses 
of corticosteroids). 
Types of interventions 
Eligible interventions include: 
 Temperature control versus no intervention; 
 Copper-silver ionization versus no intervention; 
 Chlorination versus no intervention; 
 Ultraviolet light (UVL) versus no intervention; 
 Point-of-use filtration versus no intervention 
 
 
Types of outcome measures 
Primary outcome 
a) Number of cases of hospital-acquired LD based on 
active clinical surveillance. 
Secondary outcomes 
b) Rate of Legionella positivity in environmental 
samples; 
 
Search methods for identification of 
studies 
Electronic searches 
We identified eligible studies by searching the following 
databases: 
 The Cochrane Central Register of Controlled Trials 
(CENTRAL) in The Cochrane Library using the search 
strategy described in Appendix 1; 
 MEDLINE (PubMed) using the search strategy 
described in Appendix 2. 
 
Both searches were limited to studies published in the 
English and Spanish languages. 
 
Searching other resources 
We handsearched the reference lists of all primary 
studies identified by the initial search, to identify 
further published studies for possible inclusion in the 
review. 
 
Data collection and analysis 
Selection of studies 
One author (Almeida D) initially screened the titles and 
abstracts of the search results and retrieved potentially 
relevant reports in full-text for further assessment. Two 
review authors (Almeida D, Cristovam E) 
independently reviewed all relevant reports according 
to the pre-defined inclusion criteria to determine which 
studies satisfied the inclusion criteria. We resolved any 
disagreements by consensus. 
 
Data extraction and management 
 
Data from studies satisfying the inclusion criteria were 
extracted by two review authors independently 
(Almeida D, Cristovam E). The characteristics of the 
study design, setting, participants, type of interventions 
(carefully extracting as many details as possible about 
the nature of the intervention) outcomes, results and 
risk of bias, were extracted using data extraction forms. 
 
Assessment of risk of bias in included studies 
This was conducted using the recommended approach 
for assessing risk of bias in studies included in 
Cochrane Handbook for Systematic 
Reviews of Interventions (Higgins 2011). We evaluate 
the following components for each included study: 
1. Sequence generation; 
2. Allocation concealment; 
3. Blinding of personnel and outcome assessors; 
4. Incomplete outcome data; 
5. Selective outcome reporting; 
6. Other bias. 
The validity of each study was assessed as at low risk of 
bias (low risk of bias for all key domains) unclear risk 
of bias (unclear risk of bias for one or more key 
domains) or high risk of bias (high risk of bias for one 
or more key domains) 
We decided not to exclude studies based on risk of bias 
assessment. 
 
Assessment of heterogeneity 
Heterogeneity was assessed with I² statistic, which 
provides a measure of the strength of evidence for 
heterogeneity in the studies’ results. Heterogeneity was 
considered statistically significant if P value was < 0.05. 
A rough guide to the interpretation of I2 is: 0 to 40% 
might not be important, 30 to 60% may represent 
moderate heterogeneity, 50 to 90% may represent 
substantial heterogeneity, 75 to 100% considerable 
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Data synthesis 
A comparison between intervention and control groups 
from controlled trials was made. Data was analysed 
using statistical software, Review Manager 5.2. Results 
were presented with 95% confidence intervals (CI). 
Estimates for dichotomous outcomes were reported as 
risk ratios (RR). Methods of synthesizing the studies 
depended upon design and heterogeneity. Studies of 
similar comparisons reporting the same outcome 
measure were subjected to meta-analysis. In the 
absence of heterogeneity, a fixed effect model was 
applied to pooled data. Where meta-analysis was not 




R E S U L T S 
 
Description of studies 
See: Characteristics of included studies; Characteristics 
of excluded studies 
Results of the search 
The results of electronic database and handsearching 
are outlined in Figure 1. There were no disagreements 




Figure I. Flow of studies identified in literature search.  
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Included studies 
Tree controlled trials, retrieved by electronic databases 
searches, met the inclusion criteria. Two studies 
contributed to the assessment of copper-silver 
ionization (Chen 2008, Liu 1994) and one study 
contributed to the assessment of UVL (Farr 1988) for 
preventing hospital-acquired LD. Please see 
Characteristics of included studies for more details of 
the study conditions and Risk of bias assessments for 
each study.  
Design 
All the three studies were prospective controlled trials. 
Setting 
The study by Chen 2008 was performed in a 1266-bed 
medical centre, consisted of three buildings, located in 
Taiwan. 
The study by Farr 1988 was performed in two wards of 
the University of Virginia hospital, USA. 
The study by Liu 1994 was performed in a 541-bed VA 
medical centre in Pennsylvania, USA. 
Participants 
In all of the three included studies the term 
"participants" refers to environmental samples 
subjected to microbiological testing. 
Chen 2008 assessed 25 distal sites from three hospital 
buildings. The total number of samples collected is not 
reported. We assumed that the number of samples is 
equal to number of distal sites tested. 
Farr 1988 studied 16 rooms used by renal transplant 
patients, including a total of 166 hot water samples. 
Liu 1994 assessed 47 distal sites (showerheads and 
inner surfaces of water spigots). The total number of 
samples collected is not reported. We assumed that 




In Chen 2008, a copper-silver ionization system was 
installed at the point-of-entry of buildings A and B, to 
treat a large volume of both hot and cold water, and 
building C was the control building without ionization. 
Swab samples were taken from distal sites (21 in test 
buildings and 4 in the control building) and were 
cultured for Legionella. The swab samples were taken 
before the ionization start-up, monthly for first the six 
months and bi-monthly thereafter. 
In the study of Farr 1988, they have evaluated the 
effects of an UVL system in hospital water. Two UVL 
systems were installed so both hot and cold water pipes 
leading into eight rooms, used by renal transplant 
patients, would be exposed to UVL before reaching the 
taps. Eight comparable rooms on the same two 
hospital wards served as control without UVL. Hot 
water samples were taken approximately weekly unless 
they were in use at the sampling time. 
The intervention evaluated in Liu 1994 was a copper-
silver ionization system installed on the hot 
recirculation line. Two buildings were chosen as the 
test and control (without ionization) buildings. Swabs 
of the surfaces of showerheads and inner surfaces of 
water spigots were cultured. Samples were obtained 
before start-up, a week after the system was installed 
and monthly thereafter. 
 
Outcomes 
All included studies (Chen 2008; Farr 1988; Liu 1994) 
reported the rate of Legionella positivity in 
environmental samples. 
 
Excluded studies  
Twenty-five studies were excluded because they 
violated the inclusion criteria. Twenty-four studies were 
not controlled trials (Best 1983; Best 1984; Biurrun 
1999; Blanc 2005; Borau 2000; Darelid 2002; Fisher-
Hoch 1981; Hall 2003; Helms 1988; Mietzner 1997; 
Mòdol 2007; No authors listed 2000; Ragull 2006; Rohr 
1999; Sidari 2004; Snyder 1990; Squier 2005; Srinivasan 
2003; Stout 1998; Stout 2003; Triassi 2006; Vincent-
Houdek 1993; Wilczek 1987; Zhang 2007). The study 
by Vincent-Houdek 1993 had no control group and the 
participants were confirmed cases of LD. The study by 
Johnson 1985 was excluded because the control group 
had a recent prior disinfection. 
 
Risk of bias in included studies 
 
A risk of bias table was completed for each included 
study (Risk of bias in included studies).  
Results are presented graphically by domain over all 
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Figure 2. Risk of bias graph: review authors' judgements about each risk of bias item presented 












Figure 3. Risk of bias summary: review authors' judgements about each risk of bias item for 
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Random sequence generation 
 
None of the included studies gave a clear description 
about the method used to generate the allocation 
sequence. We assumed that random sequence 




None of the included studies described the method 
used to conceal the allocation. We assumed that 
allocation concealment was not performed. 
 
Blinding of personnel and outcome assessors 
 
None of the included studies described measures used 
to blind personnel and outcome assessors from 
knowledge of which intervention a participant received. 
We assumed that blinding was not performed. 
 
Incomplete outcome data 
 





All studies fail to include results for the primary 
outcome in the review (number of cases of hospital-




In Chen 2008 the test and control group were not 
comparable (21 distal sites cultures for Legionella in 
experimental group versus 4 distal sites in control 
group). 
The Farr 1988 study had a potential source of bias 
related to the disinfection procedure undertaken during 
the intervention period. 
Information about factors such as, delay between 
samples collection and microbiological testing and the 
exact number of samples collected (in Chen 2008 and 
Liu 1994) was insufficient to assess whether an 
important risk of bias exists. 
 
All studies were rated as at high risk of bias. 
 
Effects of interventions 
Copper-silver ionization versus no intervention 
Primary outcome measure 
a) Number of cases of hospital-acquired LD 
based on active clinical surveillance. 
None of the studies reported this outcome. 
 
Secondary outcome measure 
b) Rate of Legionella positivity in environmental 
samples. 
Two studies (Chen 2008, Liu 1994), involving 72 distal 
sites samples, compared copper-silver ionization versus 
no intervention. The studies had different durations 
(Chen 2008 12 months and Liu 1994 6 months) which 
could have led to different interventions results once 
that the longer the duration of intervention the greater 
the possibility of reducing Legionella positivity in 
environmental samples. The meta-analysis showed a 
significant benefit in using copper-silver ionization 
rather than no intervention for Legionella positivity in 
distal sites, with RR = 0.04 (95% CI Fixed Effects 
0.001, 0.29) There was no evidence of heterogeneity 
between studies' results, I² = 0% (Analysis 1.1) 
However, both trials were assessed as high risk of bias 
 
Ultraviolet light versus no intervention 
Primary outcome measure 
a) Number of cases of hospital-acquired LD based 
on active clinical surveillance. 
The only included study assessing UVL did not report 
this outcome. 
Secondary outcome measure 
b) Rate of Legionella positivity in environmental 
samples. 
One study (Farr 1988), involving 166 hot water 
samples, demonstrate benefit of ultraviolet light versus 
no intervention with a RR = 0.03 (95% CI 0.00, 0.41) 
for Legionella positivity in water samples (Analysis 2.1). 
However, this trial was assessed as high risk of bias. 
 
 
D I S C U S S I O N 
 
The focus of this review was to assess the efficacy of 
interventions preventing hospital-acquired LD in 
hospitalized patients and the effect on environmental 
colonization which is associated with the risk of 
developing hospital-acquired LD. We found three 
controlled studies meeting our inclusion criteria. None 
of the included studies reported the primary outcome 
measure. These studies were based on environmental 
surveillance, reporting the impact of preventive 
measures on the colonization of the water distribution 
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systems and not on cases of human infection. Data 
obtained from environmental surveillance is important 
in this type of interventions because knowledge of 
Legionella positivity in hospital water constitute a 
significant means to risk assessment. However these 
data alone do not always allow us to assess 
comprehensively the effectiveness of interventions and 
predict future cases of disease. Therefore, an active 
clinical surveillance, that allows to accurately identify 
cases of disease, is important and the number of 
hospital-acquired LD should be considered a relevant 
outcome measure to evaluate the efficacy of 
interventions.  
The findings from our review demonstrate that copper-
silver ionization and ultraviolet light are more effective 
in reducing Legionella positivity in environmental 
samples, compared with no treatment. However 
primary studies showed methodological weaknesses. 
The quality of the body of evidence identified does not 
allow a robust conclusion regarding the effectiveness of 
interventions for preventing hospital-acquired LD.  
The limited number of controlled trials investigating 
the effectiveness of measures to prevent hospital-
acquired LD may be due to several factors. The 
feasibility of conducting a trial for the evaluation of a 
hospital preventive measure for LD is challenging 
because of the great diversity and particular features of 
water distribution systems, environmental variability of 
Legionella contamination, opportunity of having a 
control group, the absence of any established standard 
for comparison, the need for accurate in-house 
laboratory methods and high costs and effort involved 
in conducting this type of investigation. Another 
important aspect, which can lead to lack of information 
regarding this subject, is the fact that LD is an under-
diagnosed and under-reported disease in all countries. 
Legionella prevention is a complex and developing field 
of public health where decision makers, hospital 
planners and specially infection control practitioners, 
need to be kept informed of the best evidence available 
from around the world. Therefore, well design and high 
quality studies for assessing preventive modalities in 
evidence-based medicine are recommended.  
 
Potential biases in the review process 
 
We searched only for published data, imposed language 
restrictions (English and Spanish languages) and could 
not retrieved 7 studies, which titles appeared to be 
potentially relevant to our review. For these reasons we 
might have missed trials on prevention of hospital-
acquired LD and potential biases in the review process 
cannot be excluded.  
 
A U T H O R S ’ C O N C L U S I O N S 
 
Implications for practice 
Our review demonstrates that copper-silver ionization 
and ultraviolet light are beneficial, compared with no 
treatment, to prevent hospital-acquired LD. Policy 
makers, providers and users of prevention strategies for 
hospital-acquired LD may find this information useful. 
However there is insufficient evidence to make strong 
recommendations about their use. The current lack of 
research evidence forces a reliance on evidence derived 
from those studies.  
 
Implications for research 
Further research with well design and high quality 
studies is needed to determine whether the eligible 
interventions are beneficial in the prevention of 
hospital-acquired LD. Future studies may also include 
factors for which we have little information such as an 
health economic evaluation, to provide evidence on the 
most cost-effective approach, and implications of drug 
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C H A R A C T E R I S T IC S   O F   S T U D I E S 
 
 




Methods Location: Taiwan. 
Study design: Prospective controlled trial. 
Setting:1266-bed medical centre which provides a full range of medical 
services and transplantation programmes for kidney, heart, lung and bone 
marrow. The hospital consists of three buildings: Building A, a clinical 
building, including all patient wards and intensive care units (ICUs); 
Building B, an outpatient building, including clinics and offices for 
outpatient services; Building C, an emergency building, including the 
emergency department and a Burn ICU. There are four water storage 
tanks, built at the point of entry. Buildings A and B were supplied from 
three underground 500 m3 water storage tanks which were interconnected 
to each other. Building C was supplied from a separate 250 m3 water 
storage tank. 
 
Participants 21 distal sites. 
 
Interventions Copper-silver ionization installed at the point of entry to treat a large 
volume of both hot and cold water. Three copper-silver ionization systems 
(LiquiTech Inc., Bolingbrook, IL, USA) were installed at the water storage 
tanks that supplied Buildings A and B. Each system contained eight 
electrodes made from specially formulated copper-silver alloy. The output 
current was set at 4 A/60 V. The electrodes were cleaned twice a month to 
prevent scale accumulation on the surface of electrodes. The release of 
copper and silver ions was controlled by a controller with solid-state 
microprocessor circuitry. From month 1 to month 6, the controller was set 
at continuous mode which the ionization chamber was supplied at 4 A 
continuous. From month 7 to month 12, the controller was set at ‘Copper 
Analyzer’ mode. The analyser measured the copper concentration and the 
value was relayed to the controller that regulated the current automatically 
to increase or decrease the ion production to meet the target ion 
concentration in the storage tanks. 
Twenty-five distal sites (21 in test buildings, 4 in the control building) were 
cultured for Legionella. The swab samples were taken from the culture sites 
before the ionization start-up, monthly for the first six months and bi-
monthly thereafter. 
Microbiological testing: Culture, latex test and DFA 
Duration of intervention: 12 months 
 
Outcomes Rate of Legionella positivity in environmental samples. 
 
Notes  
Risk of bias 
 
Item Authors’ Judgement Description 
Random sequence generation 
(selection bias) 
 
High risk Information about the sequence generation 





High risk Information about the sequence generation 
process is not described. 
 
Blinding of participants and 
personnel (performance bias) 
 
High risk Information about the sequence generation 
process is not described. 
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Blinding of outcome assessment 
(detection bias) 
 
High risk Information about blinding of outcome 
assessment is not described. 
 
Incomplete outcome data 
(attrition bias) 
 





High risk Primary outcome and one of the secondary 




High risk Test and control groups not comparable; 
Insufficient information to assess if another 






Methods Location: Virginia, USA. 
Study design: Prospective controlled trial. 
Setting: University of Virginia Hospital. 
 
Participants 166 hot water samples from 16 rooms. 
 
Interventions Two model A 2400 UVL fittings were installed in November, 1985, so 
both hot and cold water pipes leading into eight rooms used by renal 
transplant patients on two hospital floors, would be exposed to UVL 
before reaching the taps. New copper pipes were installed from the main 
hot and cold lines to UVL fittings and from them to the eight rooms being 
served. The taps and showerheads in patients’ rooms were not replaced . 
The UVL fitting was equipped with an electronic monitor visually 
indicating the level of emission and connected to an audio alarm, which 
sounded when there was a malfunction resulting in reduced irradiation. 
Water filters with pore size of 5µm were installed 35cm before each lamp 
to remove debris from the water. The filter was removed and replaced 
every 2 months. In December, 1985, all piped leading to all rooms on the 
two floors, including the eight study rooms, were disinfected (1liter sodium 
hypochlorite and 125ml hydrogen peroxide).Water was flushed through 
each tap until the disinfectant solution was detected by means of a 
chemical dipstick indicator. The tap was then closed and left undisturbed 
for 2h. After this period all taps on the wards were flushed until the 
disinfectant could no longer be detected. 
Hot water samples were taken from the four private rooms with UVL-
treated water and from four comparable private rooms with untreated 
hospital water on each of the two involved hospital wards. Rooms were 
sampled approximately weekly unless they were in use at the sampling 
time. 
Microbiological testing: Culture (BCYE) and DFA. 
Duration of intervention: 9 months. 
 
Outcomes Rate of Legionella positivity in environmental samples. 
 
Notes  
Risk of bias 
 
Item Authors’ Judgement Description 
Random sequence generation 
(selection bias) 
 
High risk Information about the sequence generation 
process is not described. 
 
 





High risk Information about the sequence generation 
process is not described. 
 
Blinding of participants and 
personnel (performance bias) 
 
High risk Information about the sequence generation 
process is not described. 
 
Blinding of outcome assessment 
(detection bias) 
 
High risk Information about blinding of outcome 
assessment is not described. 
 
Incomplete outcome data 
(attrition bias) 
 





High risk Primary outcome and one of the secondary 




High risk Potential source of bias related to the 
disinfection procedure undertaken during the 
intervention period; Insufficient information to 




Methods Location:  Pennsylvania, USA. 
Study design: Prospective controlled trial. 
Setting: 541-bed VA medical center. 
Participants 47 distal sites (showerheads and inner surfaces of water spigots). 
 
Interventions Two buildings were chosen as the test and control buildings. Both had the 
same water supply with two instantaneous steam heating units. Two 
copper-silver ionization flow cells were installed in parallel on the hot 
water recirculation line at the test building. The output current is adjustable 
at the control unit and was set at 3 A, 40 V. The electrodes were cleaned 
once a month and whenever the amperage dropped to <2 A or the copper 
concentration level was <0.1 ppm. Both copper and silver ion 
concentrations were subsequently determined by atomic absorption 
spectroscopy. The copper-silver ionization system was activated without 
prior disinfection of the piping and distal sites. One pair of electrodes was 
connected. At 4 and 6 weeks, additional pairs of electrodes were installed 
because of suboptimal copper and silver concentrations. Finally, a higher 
power output controller was installed at 8 weeks (maximum; 5.0 A, 50 V). 
Swabs of the surfaces of showerheads and inner surfaces of water spigots 
were cultured. Samples were obtained before start-up, I week after the 
system was installed, and monthly thereafter. Water samples were collected 
from the recirculation line before and after the water passed through the 
ionization units. 
Microbiological testing: Standardized culture protocol. 
Duration of intervention: 6 months. 
 
Outcomes Rate of Legionella positivity in environmental samples. 
 
Notes  
Risk of bias 
 
Item Authors’ Judgement Description 
Random sequence generation 
(selection bias) 
 
High risk Information about the sequence generation 





High risk Information about the sequence generation 
process is not described. 
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Blinding of participants and 
personnel (performance bias) 
 
High risk Information about the sequence generation 
process is not described. 
 
Blinding of outcome assessment 
(detection bias) 
 
High risk Information about blinding of outcome 
assessment is not described. 
 
Incomplete outcome data 
(attrition bias) 
 





High risk Primary outcome and one of the secondary 




Unclear risk Insufficient information to assess whether an 
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Study Reason for exclusion 
Best 1983 Not a controlled study 
Best 1984 Not a controlled study 
Biurrun 1999 Not a controlled study 
Blanc 2005 Not a controlled study 
Borau 2000 Not a controlled study 
Darelid 2002 Not a controlled study 
Fisher-Hoch 1981 Not a controlled study 
Hall 2003 Not a controlled study 
Helms 1988 Not a controlled study 
Johnson 1985 Recent prior intervention on control group  
Marchesi 2011 Not a controlled study 
Mòdol 2007 Not a controlled study 
Mietzner 1997 Not a controlled study 
Ragull 2006 Not a controlled study 
No authors listed 2000 Not a controlled study 
Rohr 1999 Not a controlled study 
Snyder 1990 Not a controlled study 
Srinivasan 2003 Not a controlled study 
Stout 1998 Not a controlled study 
Stout 2003 Not a controlled study 
Triassi 2006 Not a controlled study 
Vincent-Houdeck 1993 Not a controlled study ; Participants had pre-existing LD 
Wilczek 1987 Not a controlled study 
Zhang 2007 Not a controlled study 
 
Interventions for Preventing Hospital-Acquired Legionnaires’ Disease (Review)   19 
 
D A T A   A N D   A N A L Y S E S  
 
Analysis 1.1.  
Comparison 1: Copper-silver ionization versus no intervention 






Comparison 2: Ultraviolet light versus no intervention 
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A P P E N D I C E S 
 
Appendix 1. Search strategy for the Cochrane Central Register of Controlled Trials 
 
#1 (Legionnaires' disease OR Legionellosis OR Legionella) AND nosocomial  
#2 (Healthcare associated AND (Legionnaires' disease OR Legionellosis OR Legionella)) 
#3 (Legionnaires' disease OR Legionellosis OR Legionella) AND hospital acquired  
#4 (Legionnaires' disease OR Legionellosis OR Legionella) AND disinfection methods  
#5 (Legionnaires' disease OR Legionellosis OR Legionella) AND prevention 
#6 (Legionnaires' disease OR Legionellosis OR Legionella) 
#7 Legionnaires' disease 




Appendix 2. Search strategy for MEDLINE (PubMed) 
 
#1 (Legionnaires' disease OR Legionellosis  OR Legionella) AND prevention AND study 
#2 (Legionnaires' disease OR Legionellosis OR Legionella) AND prevention AND trial 
#3 (Legionnaires' disease OR Legionellosis OR Legionella) AND disinfection-methods 
#4 (Legionnaires' disease OR Legionellosis OR Legionella) AND copper-silver ionization 
#5 (Legionnaires' disease OR Legionellosis OR Legionella) AND filters  
#6 (Legionnaires' disease OR Legionellosis OR Legionella) AND temperature control  
#7 (Legionnaires' disease OR Legionellosis OR Legionella) AND oxidizing biocides 
#8 (Legionnaires' disease OR Legionellosis OR Legionella) AND chlorine dioxide 
#9 (Legionnaires' disease OR Legionellosis OR Legionella) AND disinfectants 
#10 (Legionnaires' disease OR Legionellosis OR Legionella) AND point-of-use filtration 
#11 (Legionnaires' disease OR Legionellosis OR Legionella) AND chlorine dioxide  
#12 (Legionnaires' disease OR Legionellosis OR Legionella) AND monochloramine  
#13 (Legionnaires' disease OR Legionellosis OR Legionella) AND hyperchlorination  
#14 (Legionnaires' disease OR Legionellosis OR Legionella) AND ultraviolet light  
#15 (Legionnaires' disease OR Legionellosis OR Legionella) AND superheat-and-flush 
 
